Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Padi1em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Padi1em1/Cya

Common Name
Padi1-KO
Product ID
S-KO-03604
Backgroud
C57BL/6JCya
Strain ID
KOCMP-18599-Padi1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Padi1-KO Mouse (Catalog S-KO-03604) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Padi1-KO
Strain ID
KOCMP-18599-Padi1-B6J-VA
Gene Name
Padi1
Product ID
S-KO-03604
Gene Alias
Pdi1
Background
C57BL/6JCya
NCBI ID
18599 (Mouse)
Modification
Conventional knockout
Chromosome
Chr 4 (Mouse)
Phenotype
MGI:1338893
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000026378
NCBI Transcript ID
NM_011059
Target Region
Exon 2~10
Size of Effective Region
~6.6 kb
Overview of Gene Research
Padi1, or peptidylarginine deiminase 1, catalyzes protein citrullination, converting protein-bound arginine residues into citrulline residues in a calcium-dependent manner [7,8]. This post-translational modification is involved in various biological processes such as immune response regulation, and it has been associated with pathways like ERK1/2-p38 and MAPK-MMP2/9 [1,3]. Padi1 is important in normal physiological processes like early embryo development [6] and keratinocyte differentiation [7,9].

In pancreatic ductal adenocarcinoma (PAAD), knockdown of Padi1 in cell lines suppressed cell migration and invasion, suggesting it may function as an oncogene regulating metastasis in vitro, likely through the ERK1/2-p38 signaling pathway [1]. In colorectal cancer (CRC), Padi1 was highly expressed, and a set of its co-expressed genes could predict CRC prognosis and immunotherapy efficacy. The high-risk group of these co-expressed genes was enriched in pathways promoting immune escape [2]. In nasopharyngeal carcinoma, lncRNA TINCR regulated the Padi1-MAPK-MMP2/9 pathway, and Padi1 was involved in tumor progression and chemoresistance [3]. Oncolytic adenoviruses expressing Padi1 showed anti-tumor activity against melanoma in mouse models, increasing activated CD8+ T cells [4]. Padi1 and Padi3 citrullinated pyruvate kinase M2, regulating glycolysis and cancer cell proliferation [5].

In conclusion, Padi1 is crucial in multiple biological processes and diseases. Its role in tumor-related processes such as metastasis, immune microenvironment modulation, and glycolysis regulation, as revealed through in vitro and in vivo studies, offers potential therapeutic targets for cancers like PAAD, CRC, nasopharyngeal carcinoma, and melanoma. Additionally, its function in early embryo development highlights its significance in normal physiological development [1-7].

References:
1. Ji, Tengfei, Ma, Keqiang, Chen, Liang, Cao, Tiansheng. . PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway. In Journal of gastrointestinal oncology, 12, 1180-1190. doi:10.21037/jgo-21-283. https://pubmed.ncbi.nlm.nih.gov/34295566/
2. Zhang, Yi-Ran, Zhang, Lei, Li, Feng, Gong, Chao, Pan, Yun-Long. 2022. PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy. In Journal of oncology, 2022, 8394816. doi:10.1155/2022/8394816. https://pubmed.ncbi.nlm.nih.gov/36471887/
3. Zheng, Zi-Qi, Li, Zhi-Xuan, Guan, Jia-Li, Liu, Na, Sun, Ying. 2020. Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance. In Cancer research, 80, 5174-5188. doi:10.1158/0008-5472.CAN-19-3626. https://pubmed.ncbi.nlm.nih.gov/33067266/
4. Kuryk, Lukasz, Møller, Anne-Sophie W. 2023. Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models. In Molecular therapy oncolytics, 28, 158-170. doi:10.1016/j.omto.2023.01.002. https://pubmed.ncbi.nlm.nih.gov/36816748/
5. Coassolo, Sébastien, Davidson, Guillaume, Negroni, Luc, Romier, Christophe, Davidson, Irwin. 2021. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. In Nature communications, 12, 1718. doi:10.1038/s41467-021-21960-4. https://pubmed.ncbi.nlm.nih.gov/33741961/
6. Zhang, Xiaoqian, Liu, Xiaoqiu, Zhang, Mei, Coonrod, Scott A, Zhang, Xuesen. 2016. Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development. In Scientific reports, 6, 38727. doi:10.1038/srep38727. https://pubmed.ncbi.nlm.nih.gov/27929094/
7. Dong, Sijun, Ying, Shibo, Kojima, Toshio, Simon, Michel, Takahara, Hidenari. 2007. Crucial roles of MZF1 and Sp1 in the transcriptional regulation of the peptidylarginine deiminase type I gene (PADI1) in human keratinocytes. In The Journal of investigative dermatology, 128, 549-57. doi:. https://pubmed.ncbi.nlm.nih.gov/17851584/
8. Ying, Shibo, Dong, Sijun, Kawada, Akira, Simon, Michel, Takahara, Hidenari. 2008. Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes. In Journal of dermatological science, 53, 2-9. doi:10.1016/j.jdermsci.2008.09.009. https://pubmed.ncbi.nlm.nih.gov/19004619/
9. Hu, Lizhi, Bikle, Daniel D, Oda, Yuko. 2013. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation. In The Journal of steroid biochemistry and molecular biology, 144 Pt A, 237-41. doi:10.1016/j.jsbmb.2013.11.002. https://pubmed.ncbi.nlm.nih.gov/24239508/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research